This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Santner, S. J. Articles by Santen, R. J. Search for Related Content PubMed PubMed Citation Articles by Santner, S. J. Articles by Santen, R. J.

Comparative Rates of Androgen Production and Metabolism in Caucasian and Chinese Subjects¹

Department of Medicine, Division of Endocrinology, Pennsylvania State University, Milton S. Hershey Medical Center (S.J.S., B.A., M.S., L.M.D., R.J.S.), Hershey, Pennsylvania 17033; the National Research Institute for Family Planning (G.-y.Z. G.-h.Z.), Beijing 100081, China; the Department of Medicine, University of California-Los Angeles-Harbor General Hospital (C.W.), Torrance, California 90509; and the Clinical Mass Spectrometry Facility, Children’s Hospital, Oakland Research Institute (C.S.), Oakland, California 94609

Address all correspondence and requests for reprints to: Dr. Richard J. Santen, Division of Endocrinology, Department of Internal Medicine, University of Virginia Medical School, Jordan Annex, Room 2232, Box 513, Jefferson Park Avenue, Charlottesville, Virginia 22908.

Clinically apparent prostate cancer occurs more commonly among Caucasians living in Western countries than in Chinese in the Far East. Prior studies demonstrated diminished facial and body hair and lower levels of plasma 3-androstanediol glucuronide and androsterone glucuronide in Chinese than in Caucasian men. Based upon these findings, investigators postulated that Chinese men could have diminished 5-reductase activity with a resultant decrease in prostate tissue dihydrotestosterone levels and clinically apparent prostate cancer. An alternative hypothesis suggests that decreased 3-androstanediol glucuronide and androsterone glucuronide levels might reflect reduced production of androgenic ketosteroid precursors as a result of genetic or environmental factors. The present study examined 5-reductase activity, androgenic ketosteroid precursors, and the influence of genetic and environmental/dietary factors in groups of Chinese and Caucasian men. We found no significant differences in the ratios of 5ß-:5-reduced urinary steroids (a marker of 5-reductase activity) between Chinese subjects living in Beijing, China, and Caucasians living in Pennsylvania. To enhance the sensitivity of detection, we used an isotopic kinetic method to directly measure 5-reductase activity and found no difference in testosterone to dihydrotestosterone conversion ratios between groups. Then, addressing the alternative hypothesis, we found that the Caucasian subjects excreted significantly higher levels of individual and total androgenic ketosteroids than did their Chinese counterparts. To distinguish genetic from environmental/dietary factors as a cause of these differences, we compared Chinese men living in Pennsylvania and a similar group living in Beijing, China. We detected a reduction in testosterone production rates and total plasma testosterone and sex hormone-binding levels, but not in testosterone MCRs in Beijing Chinese as a opposed to those living in Pennsylvania. Comparing Pennsylvania Chinese with their Caucasian counterparts, we detected no significant differences in total testosterone, free and weakly bound testosterone, sex hormone-binding globulin levels, and testosterone production rates. Taken together, these studies suggest that environmental/dietary, but not genetic, factors influence androgen production and explain the differences between Caucasian and Chinese men.

This article has been cited by other articles:

				C. Swanson, M. Lorentzon, L. Vandenput, F. Labrie, A. Rane, J. Jakobsson, S. Chouinard, A. Belanger, and C. Ohlsson Sex Steroid Levels and Cortical Bone Size in Young Men Are Associated with a Uridine Diphosphate Glucuronosyltransferase 2B7 Polymorphism (H268Y) J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3697 - 3704. [Abstract] [Full Text] [PDF]

				C. Wang, P. Christenson, and R. Swerdloff Clinical Relevance of Racial and Ethnic Differences in Sex Steroids J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2433 - 2435. [Full Text] [PDF]

				H. J. Litman, S. Bhasin, C. L. Link, A. B. Araujo, J. B. McKinlay, and for the Boston Area Community Health Survey Invest Serum Androgen Levels in Black, Hispanic, and White Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4326 - 4334. [Abstract] [Full Text] [PDF]

				D. J. Handelsman The Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in Sport J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1646 - 1653. [Abstract] [Full Text] [PDF]

				T. Iwamoto, S. Nozawa, M. Yoshiike, T. Hoshino, K. Baba, T. Matsushita, S.N. Tanaka, M. Naka, N.E. Skakkebaek, and N. Jorgensen Semen quality of 324 fertile Japanese men Hum. Reprod., March 1, 2006; 21(3): 760 - 765. [Abstract] [Full Text] [PDF]

				C. Wang, X. H. Wang, A. L. Nelson, K. K. Lee, Y. G. Cui, J. S. Tong, N. Berman, L. Lumbreras, A. Leung, L. Hull, et al. Levonorgestrel Implants Enhanced the Suppression of Spermatogenesis by Testosterone Implants: Comparison between Chinese and Non-Chinese Men J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 460 - 470. [Abstract] [Full Text] [PDF]

				J. Jakobsson, L. Ekstrom, N. Inotsume, M. Garle, M. Lorentzon, C. Ohlsson, H.-K. Roh, K. Carlstrom, and A. Rane Large Differences in Testosterone Excretion in Korean and Swedish Men Are Strongly Associated with a UDP-Glucuronosyl Transferase 2B17 Polymorphism J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 687 - 693. [Abstract] [Full Text] [PDF]

				A. B. Singh, M. L. Lee, I. Sinha-Hikim, M. Kushnir, W. Meikle, A. Rockwood, S. Afework, and S. Bhasin Pharmacokinetics of a Testosterone Gel in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 136 - 144. [Abstract] [Full Text] [PDF]

				J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF]

				C. Wang, D. H. Catlin, B. Starcevic, D. Heber, C. Ambler, N. Berman, G. Lucas, A. Leung, K. Schramm, P. W. N. Lee, et al. Low-Fat High-Fiber Diet Decreased Serum and Urine Androgens in Men J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3550 - 3559. [Abstract] [Full Text] [PDF]

				A. Stone, L. D. Ratnasinghe, G. L. Emerson, R. Modali, T. Lehman, G. Runnells, A. Carroll, W. Carter, S. Barnhart, A. A. Rasheed, et al. CYP3A43 Pro340Ala Polymorphism and Prostate Cancer Risk in African Americans and Caucasians Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1257 - 1261. [Abstract] [Full Text] [PDF]

				K. L. Matthiesson, J. K. Amory, R. Berger, A. Ugoni, R. I. McLachlan, and W. J. Bremner Novel Male Hormonal Contraceptive Combinations: The Hormonal and Spermatogenic Effects of Testosterone and Levonorgestrel Combined with a 5{alpha}-Reductase Inhibitor or Gonadotropin-Releasing Hormone Antagonist J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 91 - 97. [Abstract] [Full Text] [PDF]

				C. Wang, D. H. Catlin, B. Starcevic, A. Leung, E. DiStefano, G. Lucas, L. Hull, and R. S. Swerdloff Testosterone Metabolic Clearance and Production Rates Determined by Stable Isotope Dilution/Tandem Mass Spectrometry in Normal Men: Influence of Ethnicity and Age J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2936 - 2941. [Abstract] [Full Text] [PDF]

				L. Turner, A. J. Conway, M. Jimenez, P. Y. Liu, E. Forbes, R. I. McLachlan, and D. J. Handelsman Contraceptive Efficacy of a Depot Progestin and Androgen Combination in Men J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4659 - 4667. [Abstract] [Full Text] [PDF]

				M. C. Meriggiola, T. M.M. Farley, and M. T. Mbizvo A Review of Androgen-Progestin Regimens for Male Contraception J Androl, July 1, 2003; 24(4): 466 - 483. [Full Text] [PDF]

				R. A. Anderson, A. M. Wallace, N. Sattar, N. Kumar, and K. Sundaram Evidence for Tissue Selectivity of the Synthetic Androgen 7{alpha}-Methyl-19-Nortestosterone in Hypogonadal Men J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2784 - 2793. [Abstract] [Full Text] [PDF]

				D. J. Handelsman Hormonal Male Contraception--Lessons from the East When the Western Market Fails J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 559 - 561. [Full Text] [PDF]

				R. A. Anderson and D. T. Baird Male Contraception Endocr. Rev., December 1, 2002; 23(6): 735 - 762. [Abstract] [Full Text] [PDF]

				R. E. Gerstenbluth, P. N. Maniam, E. W. Corty, and A. D. Seftel Prostate-Specific Antigen Changes in Hypogonadal Men Treated With Testosterone Replacement J Androl, November 1, 2002; 23(6): 922 - 926. [Abstract] [Full Text] [PDF]

				R.A. Anderson, Z.M. van der Spuy, O.A. Dada, S.K. Tregoning, P.M. Zinn, O.A. Adeniji, T.A. Fakoya, K.B. Smith, and D.T. Baird Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone Hum. Reprod., November 1, 2002; 17(11): 2869 - 2877. [Abstract] [Full Text] [PDF]

				D. Kinniburgh, H. Zhu, L. Cheng, A.T. Kicman, D.T. Baird, and R.A. Anderson Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men Hum. Reprod., June 1, 2002; 17(6): 1490 - 1501. [Abstract] [Full Text] [PDF]

				F. L. Bellino NIA Supports Minority Investigators and Research that Addresses Health Disparities Between Minority and Non-Minority Elderly Populations Sci. Aging Knowl. Environ., February 13, 2002; 2002(6): vp1 - 1. [Full Text]

				B. Yu and D. J. Handelsman Pharmacogenetic Polymorphisms of the AR and Metabolism and Susceptibility to Hormone- Induced Azoospermia J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4406 - 4411. [Abstract] [Full Text] [PDF]

				A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390. [Full Text] [PDF]

				M. C. Bosland Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66. [Abstract] [Full Text] [PDF]

				T. Shaneyfelt, R. Husein, G. Bubley, and C. S. Mantzoros Hormonal Predictors of Prostate Cancer: A Meta-Analysis J. Clin. Oncol., February 14, 2000; 18(4): 847 - 847. [Abstract] [Full Text] [PDF]

				M. Marcelli and G. R. Cunningham Hormonal Signaling in Prostatic Hyperplasia and Neoplasia J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3463 - 3468. [Full Text] [PDF]

				B. Jin, L. Turner, Z. Zhou, E. L. Zhou, and D. J. Handelsman Ethnicity and Migration as Determinants of Human Prostate Size J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3613 - 3619. [Abstract] [Full Text] [PDF]

				G.-y. Zhang, Y.-q. Gu, X.-h. Wang, Y.-g. Cui, and W. J. Bremner A Clinical Trial of Injectable Testosterone Undecanoate as a Potential Male Contraceptive in Normal Chinese Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3642 - 3647. [Abstract] [Full Text] [PDF]